-
公开(公告)号:US11472805B2
公开(公告)日:2022-10-18
申请号:US15736942
申请日:2016-06-09
申请人: Pfizer Inc.
发明人: Thomas Allen Chappie , Nandini Chaturbhai Patel , Patrick Robert Verhoest , Christopher John Helal , Simone Sciabola , Erik Alphie LaChapelle , Travis T. Wager , Ramalakshmi Yegna Chandrasekaran
IPC分类号: C07D471/14 , C07D491/147 , C07D491/22 , C07D513/14 , C07D519/00 , C07D487/04 , C07D487/14 , C07D498/22 , C07D471/22
摘要: The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R1, R2, R3a, R3b, R4a, R4b and n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.
-
公开(公告)号:US20230146535A1
公开(公告)日:2023-05-11
申请号:US17964491
申请日:2022-10-12
申请人: PFIZER INC.
发明人: Thomas Allen Chappie , Nandini Chaturbhai Patel , Patrick Robert Verhoest , Christopher John Helal , Simone Sciabola , Erik Alphie LaChapelle , Travis T. Wager , Ramalakshmi Yegna Chandrasekaran
IPC分类号: C07D471/14 , C07D491/147 , C07D491/22 , C07D513/14 , C07D519/00 , C07D487/04 , C07D487/14 , C07D498/22 , C07D471/22
CPC分类号: C07D471/14 , C07D491/147 , C07D491/22 , C07D513/14 , C07D519/00 , C07D487/04 , C07D487/14 , C07D498/22 , C07D471/22
摘要: The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R1, R2, R3a, R3b, R4a, R4b and n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.
-
公开(公告)号:US20190263816A1
公开(公告)日:2019-08-29
申请号:US15736942
申请日:2016-06-09
申请人: Pfizer Inc.
发明人: Thomas Allen Chappie , Nandini Chaturbhai Patel , Patrick Robert Verhoest , Christopher John Helal , Simone Sciabola , Erik Alphie LaChapelle , Travis T. Wager , Ramalakshmi Yegna Chandrasekaran
IPC分类号: C07D471/14 , C07D491/147 , C07D513/14 , C07D519/00 , C07D491/22
摘要: The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R1, R2, R3a, R3b, R4a, R4b and n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.
-
公开(公告)号:US12049465B2
公开(公告)日:2024-07-30
申请号:US17886807
申请日:2022-08-12
申请人: PFIZER INC.
发明人: Thomas Allen Chappie , Nandini Chaturbhai Patel , Patrick Robert Verhoest , Christopher John Helal , Simone Sciabola , Erik Alphie LaChapelle , Travis T. Wager , Ramalakshmi Yegna Chandrasekaran
IPC分类号: C07D471/14 , C07D471/22 , C07D487/04 , C07D487/14 , C07D491/147 , C07D491/22 , C07D498/22 , C07D513/14 , C07D519/00
CPC分类号: C07D471/14 , C07D471/22 , C07D487/04 , C07D487/14 , C07D491/147 , C07D491/22 , C07D498/22 , C07D513/14 , C07D519/00
摘要: The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R1, R2, R3a, R3b, R4a, R4b and n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.
-
公开(公告)号:US20230002386A1
公开(公告)日:2023-01-05
申请号:US17886807
申请日:2022-08-12
申请人: PFIZER INC.
发明人: Thomas Allen Chappie , Nandini Chaturbhai Patel , Patrick Robert Verhoest , Christopher John Helal , Simone Sciabola , Erik Alphie LaChapelle , Travis T. Wager , Ramalakshmi Yegna Chandrasekaran
IPC分类号: C07D471/14 , C07D491/147 , C07D491/22 , C07D513/14 , C07D519/00 , C07D487/04 , C07D487/14 , C07D498/22 , C07D471/22
摘要: The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R1, R2, R3a, R3b, R4a, R4b and n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.
-
-
-
-